Holen Sie sich die Stockscreener-App
2.43
0.83%
0.0201
Schlusskurs vom Vortag:
$2.4099
Offen:
$2.42
24-Stunden-Volumen:
48,892
Relative Volume:
1.90
Marktkapitalisierung:
$17.07M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-7.72M
KGV:
-0.9207
EPS:
-2.6394
Netto-Cashflow:
$-6.25M
1W Leistung:
+11.47%
1M Leistung:
+23.98%
6M Leistung:
+38.07%
1J Leistung:
-47.52%
1-Tages-Spanne:
$2.365
$2.48
1-Wochen-Bereich:
$2.1799
$2.5475
52-Wochen-Spanne:
$1.55
$5.59
Edesa Biotech Inc Stock (EDSA) Company Profile
Firmenname
Edesa Biotech Inc
Sektor
Branche
Telefon
(905) 475-1234
Adresse
100 SPY COURT, MARKHAM, ON
Vergleichen Sie EDSA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EDSA
Edesa Biotech Inc
|
2.43 | 15.31M | 0 | -7.72M | -6.25M | -2.6394 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Edesa Biotech Inc Aktie (EDSA) Neueste Nachrichten
What analysts say about Edesa Biotech Inc. stockFree Investment Timing Strategies - jammulinksnews.com
Edesa Biotech Inc. Stock Analysis and ForecastConsistent double returns - jammulinksnews.com
Is Edesa Biotech Inc. a good long term investmentOverwhelming profit margins - Autocar Professional
What drives Edesa Biotech Inc. stock priceFree Consultation - printweek.in
Edesa Biotech Insiders May Regret Not Buying More, Market Cap Hits US$16m - simplywall.st
What makes Edesa Biotech Inc. stock price move sharplyElite Stock Shortlist - Newser
How Edesa Biotech Inc. stock performs during market volatilityGrowth Stock Monitor - Newser
Why Edesa Biotech Inc. stock attracts strong analyst attentionMomentum Swing Watchlist - Newser
Edesa Biotech's JUST BREATHE Study Advances ARDS Treatment with Promising Progress - AInvest
Edesa Biotech Advances ARDS Treatment with JUST BREATHE Study - TipRanks
Edesa Biotech (NASDAQ:EDSA) Shares Down 1% – Here’s Why - Defense World
H.C. Wainwright Maintains Edesa Biotech(EDSA.US) With Buy Rating, Maintains Target Price $5 - 富途牛牛
Edesa Biotech secures up to C$23 million in funding under the Federal Government’s Strategic Innovation Fund for pivotal clinical study - Fasken
Edesa Biotech, Inc. closes US$10 million bought deal offering of common shares - Fasken
Edesa Biotech completes US$15 million private placement - Fasken
40,944 Shares in Edesa Biotech, Inc. (NASDAQ:EDSA) Bought by Citadel Advisors LLC - Defense World
Edesa Biotech Shareholders Approve Key Proposals at AGM - TipRanks
Edesa Biotech (EDSA) Receives Buy Rating from Lucid Capital | ED - GuruFocus
Zacks Small Cap Reduces Earnings Estimates for Edesa Biotech - Defense World
EDSA: Advancing EB06 for the Treatment of Vitiligo - Research Tree
EDSA: Advancing EB06 for the Treatment of Vitiligo… - Yahoo Finance
Positive Signs As Multiple Insiders Buy Edesa Biotech Stock - Yahoo Finance
Edesa Biotech Reports Fiscal 2nd Quarter 2025 Results - GlobeNewswire
Edesa Biotech Shifts Focus to Vitiligo Treatment in Q2 2025 - TipRanks
Edesa Biotech Q2 EPS USD -0.3 - marketscreener.com
Edesa Biotech Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Edesa Biotech Reports Q2 2025 Financial Results and Advances Vitiligo Drug Development Efforts - Nasdaq
Edesa Biotech Advances Novel Vitiligo Treatment with $15M Backing from Healthcare Investors - Stock Titan
Edesa Biotech Inc expected to post a loss of 29 cents a shareEarnings Preview - TradingView
Edesa Biotech (EDSA) to Release Quarterly Earnings on Friday - Defense World
Edesa Biotech to Present at 2024 Bloom Burton Healthcare Investor Conference - TipRanks
Edesa Biotech to Present at 2024 Bloom Burton & Co. Healthcare Investor Conference in Toronto - Nasdaq
Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference - GlobeNewswire
Edesa Biotech Showcases Immuno-Inflammatory Pipeline at Bloom Burton Healthcare Conference - Stock Titan
Finanzdaten der Edesa Biotech Inc-Aktie (EDSA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):